HIV Prevention Methods

Conference Coverage

The Latest

photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

As CROI 2021 Attests, the PrEP Revolution Is Coming

Analysis from David Alain Wohl, M.D., on new research in on HIV prevention, especially in areas that will expand and transform PrEP options.

By David Alain Wohl, M.D.

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Broadly Neutralizing Antibodies for HIV? If We Can Do It for COVID ...

David Alain Wohl, M.D., shares his thoughts on broadly neutralizing antibodies for COVID-19—and the extent to which we can hope to see similar developments in HIV.

By David Alain Wohl, M.D.
injection vials

Long-Acting HIV Treatment and PrEP Pipeline Update: So Many Formulations!

CROI 2021 featured new research on a host of long-acting antiretrovirals in development, including less-frequent treatment injections, a weekly pill for HIV treatment, injectable PrEP, vaginal PrEP rings, and PrEP implants.

By Larry Buhl
Researchers on a Zoom meeting during a CROI 2021 press conference

CROI 2021 Data Bites: HIV Prevention and Epidemiology

From new forms of PrEP to new data on HIV in the U.S., CROI 2021 has plenty of developments to report when it comes to preventing HIV and better understanding the drivers of the modern epidemic.

By Myles Helfand and Larry Buhl
CROI 2019

New COVID-19 Research and HIV Intervention Breakthroughs Are on the Menu at CROI 2021

Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.

By Larry Buhl

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.

By Michael Broder
doctor talking to unrecognizable patient

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.
Homeless Man Shaking a Person's Hand

U.S. Homeless Shelters Are Key Centers for HIV and Tuberculosis Prevention, Experts Say

HIV and TB often go hand in hand among people experiencing homelessness in the U.S.—a reality that gives public health officials an opportunity to utilize shelters in tackling both viruses at the same time.

By Larry Buhl
on a date

Real Talk at SYNChronicity 2020: Black Women Are Essential to Eliminating HIV

Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.

By Juan Michael Porter II